Compare Global X CleanTech (CTEC) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs IDEXX Laboratories, Inc. — how do they compare? Global X CleanTech trades at $60.14, while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: Global X CleanTech is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| CTEC | IDXX | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $766.68 |
52-Week Low | $41.08 | $526.44 |
Market Cap | — | $46.22B |
Enterprise Value | — | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTEC trades at $60.26, up 3.9% with mixed technical signals showing bullish moving averages but overbought RSI levels. The stock faces immediate resistance at $60 with support at $58. Fundamental data remains limited pending updated SEC filings and earnings reports. A future dividend of $0.07 is scheduled for July 2026, indicating long-term capital return plans.
The outlook appears cautiously optimistic near-term given the bullish technical momentum, though overbought conditions warrant monitoring. Key risks include incomplete fundamental visibility and market volatility. Upside potential exists if the company demonstrates strong earnings growth when financials are updated.
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
